Clinical Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors on NSCLC
Lung cancer is the leading cause of cancer-related deaths across the world, of which non-small cell lung cancer (NSCLC) accounts for 85%, and more than 50% of NSCLC patients were diagnosed with distant metastasis. The comprehensive treatment of NSCLC includes surgery, radiotherapy, chemotherapy, tar...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Chinês |
| Publicado em: |
Magazine House of Cancer Research on Prevention and Treatment
2021-10-01
|
| coleção: | Zhongliu Fangzhi Yanjiu |
| Assuntos: | |
| Acesso em linha: | http://html.rhhz.net/ZLFZYJ/html/8578.2021.21.0382.htm |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|